BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36403897)

  • 1. Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis.
    Lübke J; Schwaab J; Christen D; Elberink HO; Span B; Niedoszytko M; Gorska A; Lange M; Gleixner KV; Hadzijusufovic E; Solomianyi O; Angelova-Fischer I; Zanotti R; Bonifacio M; Bonadonna P; Shoumariyeh K; von Bubnoff N; Müller S; Perkins C; Elena C; Malcovati L; Hagglund H; Mattsson M; Parente R; Varkonyi J; Fortina AB; Caroppo F; Zink A; Brockow K; Breynaert C; Bullens D; Yavuz AS; Doubek M; Sabato V; Schug T; Niederwieser D; Hartmann K; Triggiani M; Gotlib J; Hermine O; Arock M; Kluin-Nelemans HC; Panse J; Sperr WR; Valent P; Reiter A; Jawhar M
    J Allergy Clin Immunol Pract; 2023 Feb; 11(2):581-590.e5. PubMed ID: 36403897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification.
    Trizuljak J; Sperr WR; Nekvindová L; Elberink HO; Gleixner KV; Gorska A; Lange M; Hartmann K; Illerhaus A; Bonifacio M; Perkins C; Elena C; Malcovati L; Fortina AB; Shoumariyeh K; Jawhar M; Zanotti R; Bonadonna P; Caroppo F; Zink A; Triggiani M; Parente R; von Bubnoff N; Yavuz AS; Hägglund H; Mattsson M; Panse J; Jäkel N; Kilbertus A; Hermine O; Arock M; Fuchs D; Sabato V; Brockow K; Bretterklieber A; Niedoszytko M; van Anrooij B; Reiter A; Gotlib J; Kluin-Nelemans HC; Mayer J; Doubek M; Valent P
    Allergy; 2020 Aug; 75(8):1927-1938. PubMed ID: 32108361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis.
    Kluin-Nelemans HC; Jawhar M; Reiter A; van Anrooij B; Gotlib J; Hartmann K; Illerhaus A; Oude Elberink HNG; Gorska A; Niedoszytko M; Lange M; Scaffidi L; Zanotti R; Bonadonna P; Perkins C; Elena C; Malcovati L; Shoumariyeh K; von Bubnoff N; Müller S; Triggiani M; Parente R; Schwaab J; Kundi M; Fortina AB; Caroppo F; Brockow K; Zink A; Fuchs D; Angelova-Fischer I; Yavuz AS; Doubek M; Mattsson M; Hagglund H; Panse J; Simonowski A; Sabato V; Schug T; Jentzsch M; Breynaert C; Várkonyi J; Kennedy V; Hermine O; Rossignol J; Arock M; Valent P; Sperr WR
    Theranostics; 2021; 11(1):292-303. PubMed ID: 33391475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An increased bone mineral density is an adverse prognostic factor in patients with systemic mastocytosis.
    Riffel P; Schwaab J; Lutz C; Naumann N; Metzgeroth G; Fabarius A; Schoenberg SO; Hofmann WK; Valent P; Reiter A; Jawhar M
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):945-951. PubMed ID: 31980928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of symptom-focused outcome measures for advanced and indolent systemic mastocytosis: the AdvSM-SAF and ISM-SAF
    Taylor F; Akin C; Lamoureux RE; Padilla B; Green T; Boral AL; Mazar I; Mar B; Shields AL; Siebenhaar F
    Orphanet J Rare Dis; 2021 Oct; 16(1):414. PubMed ID: 34627355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic Mastocytosis.
    Schwaab J; Cabral do O Hartmann N; Naumann N; Jawhar M; Weiß C; Metzgeroth G; Schmid A; Lübke J; Reiter L; Fabarius A; Cross NCP; Sotlar K; Valent P; Kluin-Nelemans HC; Hofmann WK; Horny HP; Panse J; Reiter A
    J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3121-3127.e1. PubMed ID: 32422371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging reveals distinct bone marrow patterns in indolent and advanced systemic mastocytosis.
    Riffel P; Jawhar M; Gawlik K; Schwaab J; Michaely HJ; Metzgeroth G; Hofmann WK; Schoenberg SO; Reiter A
    Ann Hematol; 2019 Dec; 98(12):2693-2701. PubMed ID: 31686155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of mastocytosis: an emerging challenge in applied hematology.
    Valent P
    Hematology Am Soc Hematol Educ Program; 2015; 2015():98-105. PubMed ID: 26637707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and prognostic impact of blood-circulating tumor mast cells in mastocytosis.
    Henriques A; Muñoz-González JI; Sánchez-Muñoz L; Matito A; Torres-Rivera L; Jara-Acevedo M; Caldas C; Mayado A; Pérez-Pons A; García-Montero AC; Álvarez-Twose I; Orfao A
    Blood; 2022 Jan; 139(4):572-583. PubMed ID: 34496018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis.
    Jawhar M; Schwaab J; Hausmann D; Clemens J; Naumann N; Henzler T; Horny HP; Sotlar K; Schoenberg SO; Cross NC; Fabarius A; Hofmann WK; Valent P; Metzgeroth G; Reiter A
    Leukemia; 2016 Dec; 30(12):2342-2350. PubMed ID: 27416984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avapritinib for Systemic Mastocytosis.
    Bose P; Verstovsek S
    Expert Rev Hematol; 2021 Aug; 14(8):687-696. PubMed ID: 34289787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and prognostic impact of
    Muñoz-González JI; Álvarez-Twose I; Jara-Acevedo M; Henriques A; Viñas E; Prieto C; Sánchez-Muñoz L; Caldas C; Mayado A; Matito A; Dasilva-Freire N; Orfao A; García-Montero AC
    Blood; 2019 Aug; 134(5):456-468. PubMed ID: 31151985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis.
    Aberer E; Sperr WR; Bretterklieber A; Avian A; Hadzijusufovic E; Kluin-Nelemans HC; Oude Elberink H; van Anrooij B; Niedoszytko M; Lange M; Górska A; Elena C; Brazzelli V; Belloni Fortina A; Caroppo F; Hartmann K; Illerhaus A; Reiter A; Jawhar M; Bonadonna P; Zanotti R; Triggiani M; Parente R; Gotlib J; Doubek M; von Bubnoff N; Fuchs D; Sabato V; Brockow K; Jäkel N; Panse J; Valent P
    J Invest Dermatol; 2021 Jul; 141(7):1719-1727. PubMed ID: 33581142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision Medicine in Systemic Mastocytosis.
    Nicolosi M; Patriarca A; Andorno A; Mahmoud AM; Gennari A; Boldorini R; Gaidano G; Crisà E
    Medicina (Kaunas); 2021 Oct; 57(11):. PubMed ID: 34833353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis.
    Jawhar M; Schwaab J; Álvarez-Twose I; Shoumariyeh K; Naumann N; Lübke J; Perkins C; Muñoz-González JI; Meggendorfer M; Kennedy V; Metzgeroth G; Fabarius A; Pfeifer D; Sotlar K; Horny HP; von Bubnoff N; Haferlach T; Cross NCP; Hofmann WK; Sperr WR; García-Montero AC; Valent P; Gotlib J; Orfao A; Reiter A
    J Clin Oncol; 2019 Nov; 37(31):2846-2856. PubMed ID: 31509472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis.
    Zanotti R; Bonifacio M; Lucchini G; Sperr WR; Scaffidi L; van Anrooij B; Oude Elberink HN; Rossignol J; Hermine O; Gorska A; Lange M; Hadzijusufovic E; Miething C; Müller S; Perkins C; Shomali W; Elena C; Illerhaus A; Jawhar M; Parente R; Caroppo F; Solomianyi O; Zink A; Mattsson M; Yavuz AS; Panse J; Varkonyi J; Doubek M; Sabato V; Breynaert C; Vucinic V; Schug T; Hägglund H; Wortmann F; Brockow K; Angelova-Fischer I; Belloni Fortina A; Triggiani M; Reiter A; Hartmann K; Malcovati L; Gotlib J; Shoumariyeh K; Niedoszytko M; Arock M; Kluin-Nelemans HC; Bonadonna P; Valent P
    Leukemia; 2022 Feb; 36(2):516-524. PubMed ID: 34545185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM.
    Lübke J; Schmid A; Christen D; Oude Elberink HNG; Span LFR; Niedoszytko M; Gorska A; Lange M; Gleixner KV; Hadzijusufovic E; Stefan A; Angelova-Fischer I; Zanotti R; Bonifacio M; Bonadonna P; Shoumariyeh K; von Bubnoff N; Müller S; Perkins C; Elena C; Malcovati L; Hagglund H; Mattsson M; Parente R; Varkonyi J; Fortina AB; Caroppo F; Brockow K; Zink A; Breynaert C; Leven T; Yavuz AS; Doubek M; Sabato V; Schug T; Hartmann K; Triggiani M; Gotlib J; Hermine O; Arock M; Kluin-Nelemans HC; Panse J; Sperr WR; Valent P; Reiter A; Schwaab J
    Blood Adv; 2024 Jun; 8(11):2890-2900. PubMed ID: 38593217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry.
    Kluin-Nelemans HC; Reiter A; Illerhaus A; van Anrooij B; Hartmann K; Span LFR; Gorska A; Niedoszytko M; Lange M; Scaffidi L; Zanotti R; Bonadonna P; Perkins C; Elena C; Malcovati L; Shoumariyeh K; von Bubnoff N; Parente R; Triggiani M; Schwaab J; Jawhar M; Caroppo F; Fortina AB; Brockow K; Zink A; Fuchs D; Kilbertus A; Yavuz AS; Doubek M; Mattsson M; Hagglund H; Panse J; Sabato V; Aberer E; Niederwieser D; Breynaert C; Várkonyi J; Kennedy V; Lortholary O; Jakob T; Hermine O; Rossignol J; Arock M; Gotlib J; Valent P; Sperr WR
    Leukemia; 2020 Apr; 34(4):1090-1101. PubMed ID: 31740811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low risk of contrast media-induced hypersensitivity reactions in all subtypes of systemic mastocytosis.
    Schwaab J; Brockow K; Riffel P; Lübke J; Naumann N; Jawhar M; Reiter L; Fabarius A; Metzgeroth G; Schoenberg SO; Hofmann WK; Reiter A; Riffel J
    Ann Allergy Asthma Immunol; 2022 Mar; 128(3):314-318. PubMed ID: 34637924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.